SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001072613-19-000064
Filing Date
2019-02-12
Accepted
2019-02-12 10:21:52
Documents
1
Group Members
ANTHONY A. FLORENCE, JR.DAVID M. MOTTFOREST BASKETTJON M. SAKODAJOSHUA MAKOWERMOHAMAD H. MAKZHOUMINEA 15 GP, LLCNEA PARTNERS 15, L.P.PETER J. BARRISPETER W. SONSINIRAVI VISWANATHANSCOTT D. SANDELL

Document Format Files

Seq Description Document Type Size
1 NEW ENTERPRISE ASSOCIATES 15, L.P. / CRISPR THERAPEUTICS AG - 13G/A (#2) crispr-sch13g_18285.htm SC 13G/A 92962
  Complete submission text file 0001072613-19-000064.txt   94831
Mailing Address 1954 GREENSPRING DRIVE, SUITE 600 TIMONIUM MD 21093
Business Address 1954 GREENSPRING DRIVE, SUITE 600 TIMONIUM MD 21093 410-842-4000
New Enterprise Associates 15, L.P. (Filed by) CIK: 0001629794 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Subject) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89674 | Film No.: 19588585
SIC: 2836 Biological Products, (No Diagnostic Substances)